Calluna Pharma

Series-A
callunapharma.com Biotech & Healthcare Oslo, Norway 11-50
Total Funding $81M
Latest Round $81M Series-A
Last Announced Jan 23, 2024
Investors 4 Backers
Decision Makers 5 Verified

About Calluna Pharma

Calluna Pharma is developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Oslo, Norway
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website callunapharma.com
Domain Registered Date Oct 24, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $81,000,000 · Series-A

    startupintros.com

  2. Milestone

    Website domain registered

    callunapharma.com

Investors & Backers

4
Forbion Capital Partners
Investinor
p53
Sarsia

Funding History

1 Round
Series-A · Jan 23, 2024

Founders & Leadership

1

Margrethe Sørgaard

Senior Vice President Clinical Operations & PV

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts